Everence Capital Management’s Repligen RGEN Stock Holding History

Everence Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Buy	+2,077	New	+$255K	0.01%	663
2026 Q1	–	Sell	-1,290	Closed	-$211K	–	875
2025 Q4	$211K	Buy	+1,290	New	+$202K	0.01%	730
2025 Q2	–	Sell	-2,040	Closed	-$260K	–	837
2025 Q1	$260K	Hold	2,040	–	–	0.02%	629
2024 Q4	$294K	Buy	+2,040	New	+$293K	0.02%	587
2019 Q2	–	Sell	-5,430	Closed	-$321K	–	666
2019 Q1	$321K	Buy	+5,430	New	+$312K	0.06%	384

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Everence Capital Management's RGEN Position: Q2 2026 in Review

Everence Capital Management opened a new position in Repligen (RGEN) in Q2 2026: 2,077 shares worth $283K. The stake represents 0.01% of the portfolio and ranks #663 among its holdings. This is a return to the name: Everence Capital Management previously reported a position in RGEN as recently as Q4 2025.

Everence Capital Management first reported a position in RGEN in Q1 2019 and has held it in 5 quarters since. The position peaked at $321K in Q1 2019. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

Everence Capital Management held 2,077 shares of Repligen worth $283K as of Q2 2026.
Repligen was a new Everence Capital Management position in Q2 2026.
Repligen made up 0.01% of Everence Capital Management's portfolio in Q2 2026, its #663 holding.
Everence Capital Management first reported a position in Repligen in Q1 2019 and has held it in 5 quarters since.
Everence Capital Management's Repligen position peaked at $321K in Q1 2019.
482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.